Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 21, 2026, titled ""Dr. Reddy s Receives DCGI Approval for Zytorvir (toripalimab) in Advanced Esophageal Squamous Cell Carcinoma, Its Second Approved Indication in India."".